Upstream Bio, Inc. (UPB)
UPB Stock Price Chart
Explore Upstream Bio, Inc. interactive price chart. Choose custom timeframes to analyze UPB price movements and trends.
UPB Company Profile
Discover essential business fundamentals and corporate details for Upstream Bio, Inc. (UPB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 Oct 2024
Employees
52.00
Website
https://upstreambio.comCEO
E. Rand Sutherland M.P.H., MPH
Description
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.
UPB Financial Timeline
Browse a chronological timeline of Upstream Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.77, while revenue estimate is $646.00K.
Earnings released on 6 Aug 2025
EPS came in at -$0.74 falling short of the estimated -$0.61 by -21.31%, while revenue for the quarter reached $937.00K , beating expectations by +35.11%.
Earnings released on 6 May 2025
EPS came in at -$0.51 falling short of the estimated -$0.49 by -4.08%, while revenue for the quarter reached $566.00K , beating expectations by +78.55%.
Earnings released on 13 Mar 2025
EPS came in at -$1.59 falling short of the estimated -$0.56 by -183.93%, while revenue for the quarter reached $613.00K , beating expectations by +87.89%.
Earnings released on 7 Nov 2024
EPS came in at -$6.96 falling short of the estimated -$0.54 by -1.20K%, while revenue for the quarter reached $607.00K , beating expectations by +52.80%.
Earnings released on 11 Oct 2024
Earnings released on 31 Dec 2023
EPS came in at -$0.14 , while revenue for the quarter reached $2.38M .
Earnings released on 30 Sept 2023
EPS came in at -$0.09 , while revenue for the quarter reached $621.00K .
UPB Stock Performance
Access detailed UPB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.